home / stock / enta / enta news

ENTA News and Press, Enanta Pharmaceuticals Inc.

Stock Information
Company Name: Enanta Pharmaceuticals Inc.
Stock Symbol: ENTA
Market: NASDAQ
Website: enanta.com
Menu
ENTA ENTA Quote ENTA Short ENTA News ENTA Articles ENTA Message Board
Get ENTA Alerts

News, Short Squeeze, Breakout and More Instantly...
ENTA - Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, and Tara L. Kieffer, Ph.D., Chief Product Strate...
ENTA - (ENTA) Investment Analysis and Advice

2024-05-10 16:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

ENTA - NanoViricides, TC BioPharm, Holdco Nuvo among healthcare movers

2024-05-07 10:01:47 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 16 out...

ENTA - US Companies Moving the Markets, Morning edition
Tue, May 07, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Nuwellis Inc. (NUWE) rose 60.3% to $0.2741 on volume of 66,284,094 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 21.1% to $0.05 on volume of 64,247,106 shares Clearmind Medicine Inc. (CMND) rose 37.6% to $1.61 on volume ...
ENTA - Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, and Tara L. Kieffer, Ph.D., Chief Product Strate...

ENTA - Enanta Pharmaceuticals, Inc. (ENTA) Q2 2024 Earnings Call Transcript

2024-05-06 20:34:10 ET Enanta Pharmaceuticals, Inc. (ENTA) Q2 2024 Earnings Conference Call May 6, 2024 04:30 PM ET Company Participants Jennifer Viera - Investor Relations Jay Luly - President and Chief Executive Officer Paul Mellett - Chief Financial Officer ...

ENTA - Enanta Pharma GAAP EPS of -$1.47 misses by $0.17, revenue of $17.05M beats by $0.84M

2024-05-06 16:04:29 ET More on Enanta Pharma Enanta Pharmaceuticals, Inc. (ENTA) Q1 2024 Earnings Call Transcript Enanta Pharma Q2 2024 Earnings Preview Enanta Pharma Q1 2024 Earnings Preview Seeking Alpha’s Quant Rating on Enanta Pharma Histor...
ENTA - Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET

Anticipates Reporting Topline Data from EDP-323 Respiratory Syncytial Virus (RSV) Challenge Study in Q3 2024 and Phase 2 Study of Zelicapavir in Pediatric RSV Patients in 2H 2024 Selection of Chronic Spontaneous Urticaria (CSU) Development Candidate Targeted for Q4 2024 Operat...

ENTA - Expected US Company Earnings on Monday, May 6th, 2024

PRA Group Inc. (PRAA) is expected to report $-0.15 for Q1 2024 Bowman Consulting Group Ltd. (BWMN) is expected to report $-0.04 for Q1 2024 Noble Corporation plc A (NE) is expected to report $0.56 for Q1 2024 Velo3D Inc. (VLD) is expected to report for Q3 2024 Axon Enterprise Inc....

ENTA - Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that effective April 29, 2024, the Compensation Committee of Enanta Pharmaceuticals’ Board of Directors g...
Next 10